Add to ORKGIntroduction: CYP19A1 encodes aromatase, the enzyme responsible for the conversion of androgens to estrogens, and may play a role in variation in outcomes among men and women with cardiovascular disease. We sought to examine genetic variation in CYP19A1 for its potential role in sex differences in cardiovascular disease outcomes. Methods: Caucasian individuals from two independent populations were assessed: 1) a prospective cohort of patients with acute coronary syndromes with 3-year mortality follow-up (n = 568) and 2) a nested case-control study from a randomized
Objectives: Male gender and family history are important risk factor for abdominal aortic aneurysm (...
Cardiovascular disease (CVD) incidence, complications and burden differ markedly between women and m...
Purpose Aromatase, encoded by the CYP19 gene, catalyzes the final step of the conversion of an-droge...
for its potential role in sex differences in cardiovascular disease outcomes. SNPs were genotyped (...
The CYP19A1 gene encodes the enzyme aromatase, which is responsible for the biosynthesis of estrogen...
Abstract. Gender differences in CAD have been clearly documented, and sex hormones have been recogni...
Objective: Coronary artery disease (CAD) is an important public health problem worldwide. Therefore,...
Copyright © 2015 Konstantina Bampali et al. This is an open access article distributed under the Cre...
Abstract—Sexual dimorphism in blood pressure (BP) regulation has been observed both in humans and ex...
Background and Aims. Gender differences in cardiovascular disease risk have been attributed to sex h...
Background: Cohort studies suggest an association be-tween variation in the estrogen receptor- gene...
Background: As aromatase-deficient mice, which are deficient in estrogens, reportedly have reduced b...
Background/Aims: There is evidence for a higher prevalence of Alzheimer's disease (AD) in women, but...
Background/Aims: There is evidence for a higher prevalence of Alzheimer's disease (AD) in women, but...
The CYP19 gene encodes for aromatase (P450arom), a key steroidogenic enzyme that catalyzes the final...
Objectives: Male gender and family history are important risk factor for abdominal aortic aneurysm (...
Cardiovascular disease (CVD) incidence, complications and burden differ markedly between women and m...
Purpose Aromatase, encoded by the CYP19 gene, catalyzes the final step of the conversion of an-droge...
for its potential role in sex differences in cardiovascular disease outcomes. SNPs were genotyped (...
The CYP19A1 gene encodes the enzyme aromatase, which is responsible for the biosynthesis of estrogen...
Abstract. Gender differences in CAD have been clearly documented, and sex hormones have been recogni...
Objective: Coronary artery disease (CAD) is an important public health problem worldwide. Therefore,...
Copyright © 2015 Konstantina Bampali et al. This is an open access article distributed under the Cre...
Abstract—Sexual dimorphism in blood pressure (BP) regulation has been observed both in humans and ex...
Background and Aims. Gender differences in cardiovascular disease risk have been attributed to sex h...
Background: Cohort studies suggest an association be-tween variation in the estrogen receptor- gene...
Background: As aromatase-deficient mice, which are deficient in estrogens, reportedly have reduced b...
Background/Aims: There is evidence for a higher prevalence of Alzheimer's disease (AD) in women, but...
Background/Aims: There is evidence for a higher prevalence of Alzheimer's disease (AD) in women, but...
The CYP19 gene encodes for aromatase (P450arom), a key steroidogenic enzyme that catalyzes the final...
Objectives: Male gender and family history are important risk factor for abdominal aortic aneurysm (...
Cardiovascular disease (CVD) incidence, complications and burden differ markedly between women and m...
Purpose Aromatase, encoded by the CYP19 gene, catalyzes the final step of the conversion of an-droge...